- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/96 - Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Patent holdings for IPC class C12N 9/96
Total number of patents in this class: 1665
10-year publication summary
|
135
|
170
|
166
|
161
|
135
|
150
|
112
|
87
|
75
|
22
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| aTyr Pharma, Inc. | 158 |
54 |
| Pangu BioPharma Limited | 106 |
38 |
| President and Fellows of Harvard College | 5792 |
37 |
| The Regents of the University of California | 18943 |
36 |
| Massachusetts Institute of Technology | 9795 |
30 |
| Novozymes A/S | 3314 |
28 |
| The Broad Institute, Inc. | 1584 |
25 |
| Bioverativ Therapeutics Inc. | 220 |
22 |
| The General Hospital Corporation | 4517 |
21 |
| Regents of the University of Minnesota | 2620 |
21 |
| Life Technologies Corporation | 3068 |
19 |
| Amicus Therapeutics, Inc. | 341 |
17 |
| The Regents of the University of Colorado, a body corporate | 2430 |
17 |
| Yale University | 2204 |
16 |
| Toyota Motor Corporation | 28582 |
15 |
| New England BioLabs, Inc. | 460 |
15 |
| Board of Regents, The University of Texas System | 5370 |
14 |
| Comera Life Sciences, Inc. | 34 |
14 |
| BASF SE | 19740 |
13 |
| Chimera Bioengineering, Inc. | 42 |
13 |
| Other owners | 1200 |